Sponsored by:
Facebook (FB)
Apple (AAPL)
JP Morgan (JPM)
Yahoo (YHOO)
Focus Stocks
Featured Stories
Ventas Declares Regular Quarterly Dividend of {loadposition newstories}.62 Per Share
Nucor To Acquire Skyline Steel LLC
Best ETFs For Facebook Exposure
Are the Bears Taking Control over F5 Networks?
Chico's FAS Reports First Quarter Earnings
New Ratings (APKT, ALNY, RDEA, CPHD, FST, HSP, LIFE, NOA)
Published on Thursday, 15 December 2011 08:24 Written by Danny Miller
New York, December 15th (TradersHuddle.com) – Following are some of the new analyst ratings before the market open.
Research Firms Initiate:
Acme Packet (NASDAQ:APKT) was initiated with a Neutral at JP Morgan.
Alnylam Pharmaceuticals (NASDAQ:ALNY) was initiated with Outperform at JMP Securities.
Ardea Biosciences, Inc. (NASDAQ:RDEA) was initiated with Market Perform at Wells Fargo.
Cepheid (NASDAQ:CPHD) was initiated wit Outperform at Credit Suisse.
Forest Oil (NYSE:FST) was initiated with a Hold at KeyBanc Capital Markets.
Hospira (NYSE:HSP), the specialty pharmaceutical and medication Delivery Company, was initiated with a Sell at UBS.
Life Technologies (NASDAQ:LIFE) was initiated with Outperform at Credit Suisse.
North American Energy Partners (NYSE:NOA) was initiated with a Buy and a target price of $9 at Sterne Agee.
Related Articles
- Upgrades & Downgrades
- Up/Downgrades: SSI, RDEA, GEOY
- Alnylam Presents Final Results from a Phase I Clinical Trial of ALN-TTR01, an RNAi Therapeutic Targeting Transthyretin (TTR) for the Treatment of Transthyretin-Mediated Amyloidosis (ATTR)
- Alnylam to Webcast Presentation at Upcoming Investor Conferences
- Alnylam Pharmaceuticals Reports First Quarter 2012 Financial Results
- Forest Oil Announces First Quarter 2012 Results
- Law Office of Brodsky & Smith, LLC Announces Investigation of Ardea Biosciences, Inc.
- Alnylam to Webcast Conference Call Discussing First Quarter 2012 Financial Results
- Forest Oil Announces Reaffirmation of Borrowing Base and Personnel Additions
- Early Research Calls ( SYMC, PPL, RAIL, BCR, AAPL, BWLD, CNI, RDEA, PGR, FITB )
Related Partner Headlines
- Acme Packet Stock Hits New 52-Week Low (APKT) - TheStreet.com
- UPDATE: UBS Investment Research Upgrades Cepheid to Buy; Opportunistic Inflection - Benzinga
- Benzinga's Top Downgrades With Color for May 14, 2012 - Benzinga
- UPDATE: GARP Research & Securities Downgrades Cepheid to Neutral; Valuation Full - Benzinga
- Acme Packet Stock Hits New 52-Week Low (APKT) - TheStreet.com
- Alnylam Presents Final Results from a Phase I Clinical Trial of ALN-TTR01, an RNAi Therapeutic Targeting Transthyretin for the Treatment of Transthyretin-Mediated Amyloidosis - Benzinga
- Acme Packet Inc. (APKT): Today's Featured Telecommunications Winner - TheStreet.com
- UPDATE: J.P. Morgan Initiates Coverage on Alnylam Pharmaceuticals - Benzinga
- Acme Packet Rises 8% After-Hours on In-Line Earnings - Benzinga
- Acme Packet Acquires IPTEGO for $21M - Benzinga
Volatile market? That's when profit potential skyrockets for options traders. Now you can get up to 50 trade opportunities a week from top options experts -- plus much more -- on our exciting new site OptionsProfits.
Try it FREE!
TradersHuddle Search
| Sponsored By:
|
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
Stock Market
Loading
